Relapsing-Remitting Multiple Sclerosis Market held a value of USD 4,976 million in 2020, at a CAGR of 3% during the assessment period of 2022 to 2028. Relapsing-remitting multiple sclerosis (RRMS) is a type of multiple sclerosis. It is the most common type of multiple sclerosis (MS), accounting for about 85% of the causes of diagnosis. […]
